neuroendocrine cancer
Showing 1 - 25 of >10,000
Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, [89Zr]Zr-BI 764532)
Not yet recruiting
- Small Cell Lung Carcinoma (SCLC)
- Neuroendocrine Neoplasms
- BI 764532
- [89Zr]Zr-BI 764532
- (no location specified)
Jul 31, 2023
Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Cancer Trial in Tampa (Pembrolizumab, Lenvatinib)
Active, not recruiting
- Neuroendocrine Tumors
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 24, 2023
HRD Cancer, SCLC, Advanced Solid Tumors Trial run by the NCI (Berzosertib, Sacituzumab Govitecan)
Recruiting
- HRD Cancer
- +2 more
- Berzosertib
- Sacituzumab Govitecan
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Patients With Neuroendocrine Cancer of the Cervix
Recruiting
- Cervical Large Cell Neuroendocrine Carcinoma
- +21 more
- Follow-Up
- Medical Chart Review
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Zhengzhou (ZG006)
Not yet recruiting
- Small Cell Lung Cancer
- Neuroendocrine Carcinoma
- ZG006
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Aug 6, 2023
Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 Trial in Iowa City ([212Pb] VMT-a-NET,
Recruiting
- Neuroendocrine Tumors
- +4 more
- [212Pb] VMT-α-NET
- [203Pb] VMT-α-NET SPECT/CT
-
Iowa City, IowaHolden Comprehensive Cancer Center at the University of Iowa
Nov 30, 2023
Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma Trial in Boston
Not yet recruiting
- Advanced Prostate Cancer
- +2 more
- 18F-fluciclovine
- PET/CT
-
Boston, Massachusetts
- +1 more
Sep 25, 2023
Surufatinib Plus Sintilimab Combined With Chemotherapy in
Recruiting
- Gastric Neuroendocrine Carcinoma
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Oct 22, 2023
Neuroendocrine Tumor Trial in Beijing (Al18F-octreotide)
Recruiting
- Neuroendocrine Tumor
-
Beijing, Chao Yang, ChinaNational Cancer Center/Cancer Hospital,Chinese Academy of Medica
Feb 19, 2023
Recurrent Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Cleveland (ONC201)
Completed
- Recurrent Neuroendocrine Tumor
- Metastatic Neuroendocrine Tumor
-
Cleveland, OhioCleveland Clinic Pediatric and Taussig Cancer Institute, Case Co
Dec 1, 2022
Neuroendocrine Tumors Trial in Beijing (Surufatinib Combined With Temozolomide and S-1)
Not yet recruiting
- Neuroendocrine Tumors
- Surufatinib Combined With Temozolomide and S-1
-
Beijing, Beijing, ChinaCancer Institute and Hospital, Chinese Academy of Medical Scienc
Sep 8, 2023
Prostate Cancer Metastatic, Neuroendocrine Tumors Trial in Atlanta, Ann Arbor (Pembrolizumab, Lenvatinib)
Recruiting
- Prostate Cancer Metastatic
- Neuroendocrine Tumors
-
Duarte, California
- +2 more
Jan 18, 2023
Neuroendocrine Carcinoma of the Bladder, Bladder Cancer Trial (Adebrelimab, Etoposide, Cisplatin)
Not yet recruiting
- Neuroendocrine Carcinoma of the Bladder
- Bladder Cancer
- Adebrelimab
- +3 more
- (no location specified)
Oct 14, 2023
Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine
Not yet recruiting
- Digestive System Neuroendocrine Tumor G1
- +5 more
- Tumor Debulking
- +5 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Aug 23, 2023
Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)
Not yet recruiting
- Neuroendocrine Tumors
- +4 more
-
Newport Beach, California
- +2 more
Aug 16, 2023
Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Chiba, Tokyo (RO7616789, Tocilizumab)
Recruiting
- Small Cell Lung Cancer
- Neuroendocrine Carcinoma
-
Chiba, Japan
- +1 more
Jan 16, 2023
Small Cell Lung Carcinoma, Neuroendocrine Tumors Trial (BI 764532)
Not yet recruiting
- Small Cell Lung Carcinoma
- Neuroendocrine Neoplasms
- BI 764532
- (no location specified)
May 22, 2023
Neuroendocrine Carcinoma Trial in Wuhan (Surufatinib and Serplulimab)
Not yet recruiting
- Neuroendocrine Carcinoma
- Surufatinib and Serplulimab
-
Wuhan, Hubei, ChinaCancer Center, Union Hospital, Tongji Medical College, Huazhong
Feb 18, 2023
Phase 1, NSCLC, SCLC Trial in United States (Oral MRT-2359)
Recruiting
- NSCLC
- +6 more
- Oral MRT-2359
-
Scottsdale, Arizona
- +7 more
Dec 20, 2022
Large Cell Neuroendocrine Carcinoma of the Lung Trial in Germany (Atezolizumab)
Recruiting
- Large Cell Neuroendocrine Carcinoma of the Lung
-
Berlin, Germany
- +13 more
Jul 20, 2022
Metastatic Malignant Tumor in the Viscera, Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic
Not yet recruiting
- Metastatic Malignant Neoplasm in the Viscera
- +4 more
- Lutetium Lu 177 Dotatate
- (no location specified)
Jan 25, 2023
Lung Cancer Trial in Baton Rouge (Pioglitazone 45 mg, Placebo)
Not yet recruiting
- Lung Cancer
- Pioglitazone 45 mg
- Placebo
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Jun 22, 2023
Genetic Predisposition Testing Program for Pancreatic
Not yet recruiting
- Pancreatic Neuroendocrine Neoplasm
- Hereditary Cancer Panel
-
Los Angeles, California
- +2 more
Feb 17, 2023